A devastating respiratory infection once thought to be primarily a childhood concern is making an alarming comeback among adults, catching the medical community and patients completely off guard.
Add Yahoo as a preferred source to see more of our stories on Google. Part of the reason whooping cough may not be in your everyday lexicon is because cases have dropped precipitously since a vaccine ...
Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. Infection can cause an ...
Young girl coughs while wrapped in a blanket. Whooping cough can cause severe bouts of coughing. But babies, who are most vulnerable to the disease, may not cough at all. Cases of whooping cough are ...
Whooping cough also usually causes a low-grade fever or no fever, while RSV, particularly in high-risk adults, can cause a high fever. Timing can help too. RSV is most prevalent from late autumn to ...
Whooping cough cases are back on the rise. The respiratory illness has had surging case numbers in 2025, outpacing 2024's data only five months into 2025. The rising trend exists both in Tennessee and ...
Morning Overview on MSN
Whooping cough cases have surged past 28,000, far above recent years
Whooping cough infected more Americans in 2025 than in any year since the pandemic began, with the CDC recording 28,783 provisional pertussis cases through the end of December. That total dwarfs the ...
A pharmacist shares what you need to know about whooping cough this winter. Most of us don’t think twice about a persistent ...
Whooping cough, a bacterial infection that can be especially dangerous for babies and young children, is on the rise. Already in 2025 the U.S. has recorded 8,485 cases. That's compared with 4,266 ...
As measles cases continue to crop up across the U.S., so too are cases of another highly contagious disease. Whooping cough, known clinically as pertussis, has caused the death of at least five, ...
A booster dose of recombinant pertussis vaccines provides sustained immunity in adolescents and young adults even after 5 years, with pertussis toxin (PT)–neutralizing antibody levels remaining 2.5- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results